Nasdaq

Recursion and Bayer Expand Fibrosis Collaboration to Include Inferential Search Capabilities

SALT LAKE CITY, Dec. 6, 2021 /PRNewswire/ -- Recursion (NASDAQ: RXRX), a clinical-stage biotechnology company decoding biology to radically improve lives by industrializing drug discovery, development ...
Nasdaq

Recursion is Granted EU Orphan Drug Designation for REC-4881 for the Potential Treatment of Familial Adenomatous Polyposis

SALT LAKE CITY, July 21, 2022 /PRNewswire/ -- Recursion (NASDAQ: RXRX), the clinical-stage biotechnology company industrializing drug discovery by decoding biology, today announced that the European ...
Seeking Alpha

Recursion Pharmaceuticals: Leveraging AI To Decode Biology And Discover Novel Therapeutics

Recursion Pharmaceuticals is a clinical-stage biotechnology company that uses AI and experimental biology to discover new treatments for diseases. The company has a technology platform called ...
Fred Hutch

Circling back to RNA sequencing data to map recursive splice sites

The human genome is just over 6 feet 8 inches long, which is 2 inches taller than the average NBA basketball player and in total, a lot of nucleotides! But what if the amount of sequence diversity ...
Business Insider

Recursion Appoints Jordan Christensen as Vice President of Engineering

SALT LAKE CITY, Aug. 16, 2021 /PRNewswire/ -- Recursion, a digital biology company industrializing drug discovery, today announced the appointment of Jordan Christensen as its Vice President of ...